Drugs of Abuse Testing: Technologies and Global Markets

Report Code: PHM013J

Publish Date: Mar 2023

Publisher: BCC Publishing

Category: Pharmaceuticals

Customize This Report

EXPLORE OFFERS

Explore Our Services

Already a member? Login to access this report free.

Report Highlights

The global market for drugs of abuse (DOA) testing is estimated to increase from $5.2 billion in 2022 to reach $8.1 billion by 2027, at a compound annual growth rate (CAGR) of 9.3% from 2022 through 2027.

Report Includes

  • 23 data tables and 42 additional tables
  • A comprehensive overview and an up-to-date analysis of the global markets for drugs of abuse (DOA) testing
  • Analyses of the global market trends, with historic market revenue (sales figures) for 2021, estimates for 2022, forecasts for 2023, and projections of compound annual growth rates (CAGRs) through 2027
  • Highlights of the upcoming market potential for DOA testing industry along with a detailed analysis of the competitive environment, industry trends, opportunities and penetration of emerging technologies within the marketplace
  • Estimation of the actual market size and revenue forecast for the global drug abuse testing market in USD million values, and its corresponding market share analysis based on the product, sample type, drug type, testing type, end user, and region
  • Technology assessment of the current and possible future legislation affecting the market in the U.S. and other emerging economies, and their influence in the market developments
  • Statistical information covering drug abuse along with its trends as well as drug classes across the key geographic regions
  • A comparative study and Porter’s Five Forces analysis considering both the micro and macro environmental factors prevailing in the market for drugs of abuse testing
  • Review of the key patent grants and patent applications on drug abuse testing technologies
  • Identification of the major stakeholders and analysis of the company competitive landscape based on their recent market developments, financial performance, and segmental revenues
  • Descriptive company profiles of the leading global players, including Abbott Laboratories, Beckmann Coulter (Danaher Corp.), Roche Diagnostics, Quest Diagnostics Inc., LifeSign and Thermo Fisher Scientific Inc.

Report Scope

The current report offers a detailed picture of the drug abuse testing market.

This report highlights the current and future market potential for drug abuse testing and provides a detailed analysis of the competitive environment, regulatory scenario, drivers, restraints, opportunities, and trends in the market. The report also covers market projections through 2027 and key market players.

This report discusses drug abuse testing and its various resources. It covers the overall drug abuse testing market, including drug testing products. The report further analyzes the market based on products, covering analyzers, consumables, laboratory services, and point-of-care devices. In addition, the report also analyzes various sample types in drug abuse testing that include blood, hair, sweat, oral, urine, and others. Furthermore, a complete regional analysis of the market is also presented in the report.

Based on geography, the market has been segmented into North America, Europe, Asia-Pacific, and the Rest of the World (which includes Latin America, the Middle East and Africa). Detailed analyses of major countries (the U.S., Canada, Germany, the U.K., France, Spain, Italy, Japan, China, and India) are covered in regional segments. For market estimates, data has been provided for 2021 as the base year, with forecasts for 2022 through 2027. Estimated values are based on revenue generated by drug abuse testing companies as total revenues. Projected and forecasted revenue values are in constant U.S. dollars that have not been adjusted for inflation.

Report Synopsis

Report Metrics Details
Base year considered 2021
Forecast period considered 2022-2027
Base year market size $4.8 billion
Market size forecast $8.1 billion
Growth rate CAGR of 9.3% for the forecast period of 2022-2027
Units considered $ Millions
Segments covered By Product, Sample Type, Drug Type, Testing Type, End User, and Region
Regions covered North America, Europe, Asia-Pacific, and Rest of the World (RoW)
Countries covered U.S., Canada, Germany, U.K., France, Japan, China and India
Key Market Drivers
  • Government Initiatives for Drug Abuse Testing
  • Increased Drug Trafficking
Companies studied
SHIMADZU CORP.SIEMENS HEALTHINEERS AG
THERMO FISHER SCIENTIFIC INC.REDWOOD TOXICOLOGY LABORATORY
RANDOX LABORATORIES LTD.ABBOTT
ACON LABORATORIES INC.AGILENT TECHNOLOGIES INC.
ALFA SCIENTIFIC DESIGNS INC.AMERICAN BIO MEDICA
BIO-RAD LABORATORIES INC.CONFIRM BIOSCIENCES
DANAHER CORP.F. HOFFMANN-LA ROCHE LTD.
IDENTA CORP.LIFESIGN LLC
MAVAND SOLUTIONSMEDTOX DIAGNOSTICS
MOSSMAN ASSOCIATESMP BIOMEDICALS
NANO-DITECH CORP.ONE STEP DETECT ASSOCIATES
ORASURE TECHNOLOGIES INC.ORTHO-CLINICAL DIAGNOSTICS
PRECHEK BIOPRINCETON BIOMEDITECH CORP.
PSYCHEMEDICSQUEST DIAGNOSTICS INC.
UCP BIOSCIENCES
Need a custom data table, graph, region, segment, companies or complete report? CUSTOMIZE NOW

Frequently Asked Questions (FAQs)

The drug abuse testing market is projected to grow from $4.8 billion in 2021 to $8.1 billion in 2027, at a compound annual growth rate (CAGR) of 9.3% during the forecast period.
The key factors driving the growth of the drug abuse testing market include:
  • Government initiatives for drug abuse testing
  • Increased drug trafficking
The drug abuse testing market is segmented based on product, sample type, testing type, end user, and region.
The urine fold segment will dominate the market by the end of 2027.
North America holds the highest share of the market.
Key companies in the market include Abbott Laboratories, Thermo fisher scientific, Roche, and others.

Analyst Credentials

BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.

Let us assist you! Our analysts are ready to tailor this report to your specific need. Talk to Our Analyst

Table of Contents

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
Title/Chapter NamePagesMember Price
Full Report: Drugs of Abuse Testing: Technologies and Global Markets159Free
Chapter- 1: Introduction8Free
Chapter- 2: Summary and Highlights2Free
Chapter- 3: Market and Technology Background7Free
Chapter- 4: Market Dynamics19Free
Chapter- 5: Regulatory Scenario31Free
Chapter- 6: Global Drugs of Abuse Testing Market by Drug Type5Free
Chapter- 7: Global Drugs of Abuse Testing Market by End User3Free
Chapter- 8: Global Drugs of Abuse Testing Market by Sample Type13Free
Chapter- 9: Global Drugs of Abuse Testing Market by Product7Free
Chapter- 10: Global Drugs of Abuse Testing Market by Testing Type8Free
Chapter- 11: Market Breakdown by Region22Free
Chapter- 12: Patent Analysis5Free
Chapter- 13: Competitive Landscape Analysis2Free
Chapter- 14: Company Profiles27Free
Published - Apr-2019| Analyst - BCC Publishing| Code - PHM013H

Report Highlights

The global market for drugs of abuse (DOA) testing should grow from $3.5 billion in 2018 to $4.6 billion by 2023 with a compound annual growth rate (CAGR) of 5.6% for the period of 2018-2023.

Published - May-2017| Analyst - Jon Evans| Code - PHM013G

Report Highlights

The global drug of abuse (DOA) testing market reached nearly $3.0 billion in 2016. This market is estimated to grow at a compound annual growth rate (CAGR) of 4.5% to reach nearly $3.9 billion by 2022 from $3.1 billion in 2017.

Published - Mar-2015| Analyst - Jon Evans| Code - PHM013F

Report Highlights

The global drug of abuse (DOA) testing market reached nearly $2.8 billion in 2014. This market is estimated to grow at a compound annual growth rate (CAGR) of 4.5% to reach almost $3.5 billion by 2019.

Published - Jul-2008| Analyst - Syamala Ariyanchira| Code - PHM013E

Report Highlights

  • The global market for DOA testing increased from $1.9 billion in 2007 to an estimated $2.0 billion by the end of 2008. It should reach $2.6 billion in 2014, for a compound annual growth rate (CAGR) of 4.6%.
  • The U.S. testing market segment generated the largest share of revenues with $1.4 billion in 2007. This is expected to reach $1.5 billion in 2008 and $2.0 billion in 2014, for a CAGR of 5.2%.
  • The European Union had the second largest market segment with $365.2 million in sales in 2007. This is expected to grow at a CAGR of 2.9% to reach $374.2 million in 2008 and $445.9 million in 2014.
Published - Jul-2002| Analyst - Ruth Scolnick| Code - PHM013D

Report Highlights

  • Drugs of abuse testing sales will reach $1.6 billion in 2007, rising at an AAGR (average annual growth rate) of 4.7%.
  • Sales in the U.S. are expected to reach $996 million in 2002 and forecasted to grow to $1.3 billion in 2007 at an AAGR of 5.4%.
  • Sales in Europe expected to be $291 million in 2002 and forecasted to grow at an AAGR of 1.8% to approximately $318 million in 2007.
  • The number of different places and applications, such as a workplace, drug court, hospital, and school, for drug testing, with blood, hair, oral fluid, sweat or urine samples, reflects the need for a variety of drug testing services and the versatility of drug testing technology.

Related Reports

Breakthrough Therapies: Market Dynamics and Investment Opportunities

Published - Dec 2024 | Publisher - BCC Publishing | Code - PHM176B

The global market for breakthrough therapy drugs was valued at $133.3 billion in 2023. This market is expected to grow from $150.6 billion in 2024 to $287.5 billion by 2029, at a compound annual growth rate (CAGR) of 13.8% from 2024 to 2029.

Point-of-Care Diagnostics: Technologies and Global Markets

Published - Oct 2024 | Publisher - BCC Publishing | Code - HLC043H

The global market for point-of-care diagnostics was valued at $36.9 billion in 2023. It is expected to grow from $40.6 billion in 2024 to $65.9 billion by the end of 2029, at a compound annual growth rate (CAGR) of 10.2% from 2024 through 2029.

3D Cell Cultures: Technologies and Global Markets

Published - Mar 2024 | Publisher - BCC Publishing | Code - BIO140D

The global market for 3D cell culture is estimated to increase from $4.6 billion in 2023 to reach $14.8 billion by 2028, at a compound annual growth rate (CAGR) of 26.5% from 2023 through 2028.

Blood Testing: Technologies and Global Markets

Published - Nov 2018 | Publisher - BCC Publishing | Code - HLC184B

The global market for blood testing will grow from nearly $53.8 billion in 2018 to $60.5 billion by 2023 with a compound annual growth rate (CAGR) of 2.4% for the period of 2018-2023.

Recent Reports

Neurology Market: A BCC Research Overview

Published - Feb 2025 | Publisher - BCC Publishing | Code - PHM215B

The global market for neurology is estimated to increase from $67.3 billion in 2024 to reach $94.8 billion by 2029, at a compound annual growth rate (CAGR) of 7.1% from 2024 through 2029.

2023 Pharmaceuticals Research Review

Published - Feb 2025 | Publisher - Various Analysts | Code - PHM099H

This Pharmaceutical Research Review provides a sampling of the type of quantitative market information, analysis and guidance that has been aiding business decision making since the inception of BCC Research in 1971.

Alzheimer's Disease Therapeutics and Diagnostics: Global Markets

Published - Dec 2024 | Publisher - BCC Publishing | Code - PHM062E

The global market for Alzheimer’s disease therapeutics and diagnostics was valued at $9 billion in 2023. This market is expected to grow from $9.7 billion in 2024 to $19.6 billion by 2029, at a compound annual growth rate (CAGR) of 15.1% from 2024 to 2029.

Laboratory Animal Models, 3D Cultures, and Organoids: Global Markets

Published - Dec 2024 | Publisher - BCC Publishing | Code - PHM204C

The global market for laboratory animal models, 3D cultures, and organoids is estimated to increase from $2.8 billion in 2024 to reach $5.0 billion by 2029, at a compound annual growth rate (CAGR) of 12.5% from 2024 through 2029.

Rare Disease Diagnostics: Technologies and Global Markets

Published - Dec 2024 | Publisher - BCC Publishing | Code - PHM227B

The global market for rare disease diagnostics is estimated to increase from $21.6 billion in 2024 to reach $34.7 billion by 2029, at a compound annual growth rate (CAGR) of 9.9% from 2024 through 2029.

Top Trending Reports

Alzheimer's Disease Therapeutics and Diagnostics: Global Markets

Published - Dec 2024 | Publisher - BCC Publishing | Code - PHM062E

The global market for Alzheimer’s disease therapeutics and diagnostics was valued at $9 billion in 2023. This market is expected to grow from $9.7 billion in 2024 to $19.6 billion by 2029, at a compound annual growth rate (CAGR) of 15.1% from 2024 to 2029.

Biomarkers: Technologies and Global Markets

Published - Jan 2025 | Publisher - BCC Publishing | Code - BIO061G

The global market for biomarkers was valued at $63.7 billion in 2023. This market is expected to grow from $70.5 billion in 2024 to $130.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 13.1% from 2024 through 2029.

In Vitro Diagnostics: Technologies and Global Markets

Published - Jan 2025 | Publisher - BCC Publishing | Code - HLC186D

The global market for In Vitro Diagnostics (IVD) is expected to grow from $94.7 billion in 2024 and is projected to reach $141.9 billion by the end of 2029, at a compound annual growth rate (CAGR) of 8.4% during the forecast period of 2024 to 2029.

OTC Drugs, Medical Devices and Diagnostics: Global Markets

Published - Jan 2025 | Publisher - BCC Publishing | Code - HLC251B

The global market for OTC drugs, medical devices, and diagnostics is estimated to increase from $251.7 billion in 2024 to reach $359.7 billion by 2029, at a compound annual growth rate (CAGR) of 7.4% from 2024 through 2029.

Liquid Biopsy Research Tools, Services and Diagnostics: Global Markets

Published - Jan 2025 | Publisher - BCC Publishing | Code - BIO150E

The global market for liquid biopsy is expected to grow from $4.6 billion in 2024 and is projected to reach $13.1 billion by the end of 2029, at a compound annual growth rate (CAGR) of 23.3% during the forecast period of 2024 to 2029.

Become A Member

BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.

Find Out More

Custom Consulting

BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.

Customize Now

Scorecard

The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.

Find Out More

Innovation Spotlight

Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.

Find Out More
Drugs of Abuse Testing: Technologies and Global Markets
Customize Report